Drugplain

Melilotus Officinalis 6 [hp_C]/1

Melilotus Officinalis · PELLET · Hahnemann Laboratories, INC.

No Recall History
Plain English

Melilotus Officinalis is an over-the-counter herbal supplement available in pellet form taken by mouth. This product is derived from sweet clover plant and is traditionally used to support circulation and reduce swelling.

Key Facts

Brand Name
Melilotus Officinalis
Generic Name
Melilotus Officinalis
NDC Code (Product)
37662-1139
Manufacturer
Hahnemann Laboratories, INC.
Strength
6 [hp_C]/1
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
08/01/2022

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

asthenia2 reports
blood pressure increased2 reports
cholelithiasis2 reports
depression2 reports
dizziness2 reports
headache2 reports
pyrexia2 reports
tremor2 reports
agitation1 reports
angiopathy1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Menopausal hot flashes*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Frequently Asked Questions

What is Melilotus Officinalis used for?

Melilotus Officinalis is an over-the-counter herbal supplement available in pellet form taken by mouth. This product is derived from sweet clover plant and is traditionally used to support circulation and reduce swelling.

Is Melilotus Officinalis a controlled substance?

Melilotus Officinalis is not classified as a controlled substance by the DEA.

What is the generic name for Melilotus Officinalis?

The generic name for Melilotus Officinalis is Melilotus Officinalis. There are 2 other brand versions of Melilotus Officinalis.

What is the NDC code for Melilotus Officinalis 6 [hp_C]/1?

The NDC (National Drug Code) for Melilotus Officinalis 6 [hp_C]/1 is 37662-1139, listed by Hahnemann Laboratories, INC..